首页> 外国专利> - LYCOPENE AND RESVERATROL COMPOSITIONS FOR NK CELL ACTIVATION RESULTING IN ANTI-NEOPLASTIC EFFECT

- LYCOPENE AND RESVERATROL COMPOSITIONS FOR NK CELL ACTIVATION RESULTING IN ANTI-NEOPLASTIC EFFECT

机译:-番茄红素和白藜芦醇成分可导致NK细胞活化从而产生抗肿瘤作用

摘要

A composition comprising a therapeutically effective amount of a carotenoid and a terpenoid, which can be taken simultaneously or sequentially with a single agent or two separate agents to elevate the activity of natural killer (NK) cells during metabolic processes. Specifically, the composition contains lycopene and resveratrol in a molar ratio of 1:10 to 10: 1, more preferably in a molar ratio of 1: 1 to 3: 1, and most preferably 3: 1. On the other hand, the preferred ratio can be expressed in a weight ratio of 1: 4 to 25: 1, more preferably 2.5: 1 to 7.5: 1, and most preferably 7.5: 1. The composition may be formulated as a medicament, dietary supplement or food for oral administration and may be provided at a dose of about 3.5 mg per 20 g of the mammalian body weight in a therapeutically effective amount, preferably 2.5: 1, have. Which can be converted to doses of 400 mg to 1000 mg per day to a typical human in need of increased NK cell activity. Preferably, the therapeutically-effective aspects of the present compositions include metabolically produced preparations, prodrug or intermediate compounds of the present compositions useful for triggering NK cells to cytotoxic or cytolytic reactions.
机译:包含治疗有效量的类胡萝卜素和类萜的组合物,其可以与单一药剂或两种单独药剂同时或依次服用,以提高代谢过程中自然杀伤(NK)细胞的活性。具体地,该组合物以1:10至10:1的摩尔比包含番茄红素和白藜芦醇,更优选以1:1至3:1的摩尔比,最优选3:1。该比率可以以1∶4至25∶1的重量比表示,更优选2.5∶1至7.5∶1,最优选7.5∶1。该组合物可以配制成药物,饮食补充剂或口服食品。并且可以以每20克哺乳动物体重约3.5mg的剂量提供治疗有效量,优选2.5∶1。对于需要增加NK细胞活性的典型人,每天可以将其转换为400 mg至1000 mg的剂量。优选地,本发明组合物的治疗有效方面包括本发明组合物的代谢产生的制剂,前药或中间化合物,其可用于引发NK细胞发生细胞毒性或细胞溶解反应。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号